Delivery Order SPE2DB22D2006-SPE2DB25FW3ES
- Not listed
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $56,610 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 500 tablets of 500 milligram methocarbamol. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 28, 2023 through September 29, 2023. No subcontractors or set aside designations were identified. The Defense...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $196.50 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 500 tablets of 750 mg methocarbamol. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 1-2, 2023. No major subcontractors or set aside designations were indicated. This delivery order was issued against an...
- The Defense Logistics Agency awarded a $541 delivery order to Amerisourcebergen Drug Corporation for 500 tablets of 500 milligram methocarbamol tablets. The firm fixed price order is for delivery to a location in Conshohocken, Pennsylvania between August 30 and 31, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a common muscle relaxant drug supports the Agency's mission to provide critical medical materiel to military...
- The Defense Logistics Agency awarded a $5,485.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 mg/10 ml bottles of methocarbamol. Amerisourcebergen will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by September 13, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen supports DLA's mission to provide logistics support for the Department of Defense and foreign...
- The Defense Logistics Agency Troop Support Medical awarded a $313,460 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562192813 ! METHOCARBAMOL 1,000 MG/10 ML 10ML. The place of performance is Conshohocken, Pennsylvania. The delivery order has a period of performance from September 15, 2023 through September 18, 2023 to supply methocarbamol, an oral muscle relaxant, in support of DLA Troop Support Medical's mission to provide the Department of Defense with medical...
- The Defense Logistics Agency Troop Support Medical awarded a $39,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 boxes containing 750 mg Methocarbamol tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency Troop Support Medical supports the...
- The Defense Logistics Agency awarded a $84,870 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 boxes containing 500 methocarbamol 500 mg tablets each. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 27, 2023 through July 28, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and other medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 25, 2025, for the supply of Methyldopa 250 mg tablets (180 count) valued at $2,334.14. This firm fixed-price contract, which is due for completion by August 26, 2025, was awarded without a set-aside designation through competitive procedures. The award is funded by the Defense Logistics Agency's Medical Supply Chain, reflecting the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3ESDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,466.29 to AmerisourceBergen Drug Corp for Methocarbamol 500 mg tablets in unit dose packaging (100 count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this prime IDC to supply medications and medical supplies supporting military healthcare systems worldwide. The Methocarbamol delivery represents a typical small-value pharmaceutical transaction within the company's extensive portfolio of generic and brand-name medications, pain management pharmaceuticals, and specialized medical commodities supporting Defense Health Agency requirements and other government healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 8/7/25 |